Literature DB >> 2567241

A monoclonal antibody to murine CD45R distinguishes CD4 T cell populations that produce different cytokines.

K Bottomly1, M Luqman, L Greenbaum, S Carding, J West, T Pasqualini, D B Murphy.   

Abstract

CD4 T cell clones have been shown to be functionally heterogeneous in the mouse. However, it is not known if normal CD4 T cells are also functionally heterogeneous, or whether functional specialization is a result of cloning and long-term culture. To approach this question, a monoclonal antibody reacting with a subset of CD4 T cells has been prepared by immunization of rats with different cloned T cell lines all sharing the same functional activity. This monoclonal antibody reacts with a subset of CD45 (T200) molecules by binding to a determinant requiring the expression of the second variable exon of the CD45 molecule. Some CD4 T cells bear high levels of this marker, while others react only weakly. This antibody was used to separate CD4 T cells into two subpopulations. The brightly staining population was found to produce interleukin (IL) 2 and not IL 4, while the weakly staining population produced IL 4 and not IL 2. These data demonstrate that CD4 T cells in normal mice are already functionally committed, and that they differentially express forms of CD45 that contain the second variable exon.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2567241     DOI: 10.1002/eji.1830190407

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  56 in total

Review 1.  Function and regulation of memory CD4 T cells.

Authors:  D P Metz; K Bottomly
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Expression of soluble isoforms of rat CD45. Analysis by electron microscopy and use in epitope mapping of anti-CD45R monoclonal antibodies.

Authors:  M N McCall; D M Shotton; A N Barclay
Journal:  Immunology       Date:  1992-06       Impact factor: 7.397

3.  Pattern of lectin binding to murine T lymphocytes.

Authors:  R A Sowalsky; B S Fox
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

4.  Anti-CD45 isoform antibodies enhance phagocytosis and gene expression of IL-8 and TNF-alpha in human neutrophils by differential suppression on protein tyrosine phosphorylation and p56lck tyrosine kinase.

Authors:  C- L Yu; H-S Yu; K-H Sun; S-C Hsieh; C-Y Tsai
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

5.  Differential presentation of hepatitis B S-preS(2) particles and peptides by macrophages and B-cell like antigen-presenting cells.

Authors:  J P Scheerlinck; G Burssens; L Brys; A Michel; P Hauser; P De Baetselier
Journal:  Immunology       Date:  1991-05       Impact factor: 7.397

6.  Phenotypic heterogeneity of intraepithelial T lymphocytes from mouse small intestine.

Authors:  K J Maloy; A M Mowat; R Zamoyska; I N Crispe
Journal:  Immunology       Date:  1991-04       Impact factor: 7.397

7.  Epitope-specific crosslinking of CD45 down-regulates membrane-associated tyrosine phosphatase activity and triggers early signalling events in human activated T cells.

Authors:  François Spertini; Veronique Perret-Menoud; Nathalie Barbier; Talal Chatila; Catherine Barbey; Blaise Corthesy
Journal:  Immunology       Date:  2004-12       Impact factor: 7.397

8.  Oral tolerance in the absence of naturally occurring Tregs.

Authors:  Daniel Mucida; Nino Kutchukhidze; Agustin Erazo; Momtchilo Russo; Juan J Lafaille; Maria A Curotto de Lafaille
Journal:  J Clin Invest       Date:  2005-06-02       Impact factor: 14.808

9.  CD4(+) CD44(v.low) cells are unique peripheral precursors that are distinct from recent thymic emigrants and stem cell-like memory cells.

Authors:  Chunfang Zhao; Idania Marrero; Aditi Narsale; Rosita Moya; Joanna D Davies
Journal:  Cell Immunol       Date:  2015-04-17       Impact factor: 4.868

10.  Interleukin 4 suppresses interleukin 2 and interferon gamma production by naive T cells stimulated by accessory cell-dependent receptor engagement.

Authors:  T Tanaka; J Hu-Li; R A Seder; B Fazekas de St Groth; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.